FORE Biotherapeutics vs Oriel Research
FORE Biotherapeutics vs Oriel Research, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: FORE Biotherapeutics is on 56/100 and Oriel Research on 12/100.
Where each one leads
FORE Biotherapeutics
- our overall score: 56/100 against 12/100
- agent readiness: 37/100 against 22/100
- domain rating: 35/100 against 0/100
- headcount: 56 against 6
Oriel Research
Leads on none of the measures we hold for both companies.
At a glance
| Measure | FORE Biotherapeutics | Oriel Research |
|---|---|---|
| What it is | Precision oncology company developing cancer therapies guided by proprietary functional genomics. | Crowdsourcing genomic data to discover disease markers and therapy correlations for personalized medicine. |
| Category | Healthcare, Drug Development, Genomics, Next Generation Sequencing | Healthcare, Genomics, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2C |
| Offering | Software | Software |
| Founded | 2011 | 2017 |
| Headquarters | Philadelphia, United States | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | FORE Biotherapeutics | Oriel Research |
|---|---|---|
| Employees | 56 | 6 |
| Headcount growthLast 12 months | +8.2% | Not published |
| Total funding | $232M | Not published |
| Latest round | Series D-2 Extension | Bootstrapped |
| Valuation | $75.0M | Not published |
| LinkedIn followers | 4,584 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | FORE Biotherapeutics | Oriel Research |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 12/100 |
| Traction | 58/100 | 8/100 |
| Team | 70/100 | Not published |
| Search visibility | 38/100 | 9/100 |
| Quality | 55/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 0/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | FORE Biotherapeutics | Oriel Research |
|---|---|---|
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
FORE Biotherapeutics vs Oriel Research: common questions
Which is better, FORE Biotherapeutics or Oriel Research?
On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 12/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do FORE Biotherapeutics and Oriel Research compare on the numbers?
FORE Biotherapeutics leads on our overall score (56/100 against 12/100), agent readiness (37/100 against 22/100), domain rating (35/100 against 0/100), headcount (56 against 6).
Read the full FORE Biotherapeutics review and pricing or the Oriel Research review and pricing. You can also browse other FORE Biotherapeutics alternatives we track.